📹 🇫🇷 Our research partners, G. Courtine, and Jocelyne Bloch, stopped by BFM Business in Paris, France last week to chat with Laure Closier and Christophe Jakubyszyn on “Good Morning Business” about our plans to commercialize our first product, the investigational ARC-EX® System, in the US later this year.
During the nearly ten-minute discussion, the pair also discussed their work using brain-computer interface technology to help a paralyzed man walk more efficiently using the power of thought and about our $20M capital raise in Europe last week. 🎤
✨Thanks to BFM Business for the thoughtful and informative conversation! We appreciate your time and interest in these important topics, including the unmet challenges of those with spinal cord injuries.
*All ONWARD Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, ARC-BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.
#EmpoweringMovement #SCI #Innovation